| Hans-Günter Meyer-Thompson | Hepatitiden
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial.
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial.
van Santen, D. K., Anders, B., Matser, A., Maher, L., Hickman, M., Lodi, S., and Prins, M. (2021) Addiction, doi.org/10.1111/add.15503.
Abstract